Genetic PD follows Mendelian inheritance
In summary, tirzepatide is the first dual receptor agonist that was recently approved for the treatment of T2D by the FDA
IVs send medication directly into the bloodstream, which allows the body to absorb it more quickly and in higher quantities than with an oral pill or supplement
By 2050, almost 60% of adults over 25 are expected to be overweight or obese, up from 29% in 1990, with the biggest growth in sub-Saharan Africa, according to a study in The Lancet External link
We have witnessed improved joint mobility in patients using GLP-1 therapy, offering a comprehensive approach to managing joint pain alongside other metabolic benefits
TZP decreases serum alanine aminotransferase and atherogenic biomarkers (chylomicrons, small dense LDL-cholesterol levels, apoB, apoC-III) (57)